Live feed
Filing
SC 13G
SC 13G0001535610-15-000047·ImmunoCellular Therapeutics, Ltd.
Schedule 13G ownership disclosure
ImmunoCellular Therapeutics, Ltd.
Security class unavailable · CUSIP: 452536105
Event date: 2015-02-12
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 5,000,000
- Percent of class
- 5.5400%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001535610-15-000047
- Form type
- SC 13G
- Filer
- ImmunoCellular Therapeutics, Ltd.
- CIK
- CIK 822411
- Filed
- Feb 19, 2015
- Reporting period
- Feb 12, 2015
- Description
- Schedule 13G beneficial ownership